Chronological changes in epidemiological characteristics of lower urinary tract urolithiasis in Japan.


Journal

International journal of urology : official journal of the Japanese Urological Association
ISSN: 1442-2042
Titre abrégé: Int J Urol
Pays: Australia
ID NLM: 9440237

Informations de publication

Date de publication:
01 2019
Historique:
received: 21 06 2018
accepted: 22 08 2018
pubmed: 12 10 2018
medline: 5 6 2019
entrez: 12 10 2018
Statut: ppublish

Résumé

To determine changes and trends in the annual incidence and epidemiological aspects of lower urinary tract stones in Japan. Data about patients who had been diagnosed by urologists in 2015 with first and recurrent lower urinary tract stones were collected from 301 hospitals approved by the Japanese Board of Urology. The estimated annual incidence according to sex, age and stone composition was compared with previous nationwide surveys between 1965 and 2005. The incidence of lower urinary tract stones in Japan has steadily increased from 4.7 per 100 000 in 1965 to 12.0 per 100 000 in 2015. However, the age standardized annual incidence of lower urinary tract stones has remained relatively stable over the same period at 5.5 per 100 000 and 6.0 per 100 000 in 1965 and 2015, respectively. The increase in incidence was most evident among individuals aged ≥80 years. The incidence of calcium oxalate stones has steadily increased among males and females, whereas that of infection-related stones has significantly decreased from 26.2% to 14.3% among men over the past 50 years. Nationwide surveys suggest a steady increase in the incidence of lower urinary tract stones over a 50-year period in Japan. This trend might reflect changes in the aging population and improved Japanese medical standards.

Identifiants

pubmed: 30308705
doi: 10.1111/iju.13817
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

96-101

Subventions

Organisme : Japanese Society on Urolithiasis Research
Pays : International

Informations de copyright

© 2018 The Japanese Urological Association.

Auteurs

Shinichi Sakamoto (S)

Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Katsuhito Miyazawa (K)

Department of Urology, Kanazawa Medical University, Kanazawa, Japan.

Takahiro Yasui (T)

Department of Nephro-Urology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.

Taro Iguchi (T)

Department of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan.

Misuzu Fujita (M)

Department of Public Health, Graduate School of Medicine, Chiba University, Chiba, Japan.

Hiroaki Nishimatsu (H)

Department of Urology, Doai Memorial Hospital, Tokyo, Japan.

Takuro Masaki (T)

Department of Urology, Harasanshin Hospital, Fukuoka, Japan.

Toru Hasegawa (T)

Department of Urology, Hasegawa Hospital, Tokyo, Japan.

Hatsuki Hibi (H)

Department of Urology, Kyoritsu General Hospital, Nagoya, Japan.

Takashi Arakawa (T)

Department of Urology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.

Ryosuke Ando (R)

Department of Nephro-Urology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.

Yoshinari Kato (Y)

Department of Urology, Kaizuka City Hospital, Kaizuka, Japan.

Noritaka Ishito (N)

Department of Urology, Kurashiki Medical Center, Kurashiki, Japan.

Satoshi Yamaguchi (S)

Department of Urology, Kitasato Hospital, Sagamihara, Japan.

Ryoji Takazawa (R)

Department of Urology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan.

Masao Tsujihata (M)

Department of Urology, Osaka Rosai Hospital, Sakai, Japan.

Makoto Taguchi (M)

Department of Urology and Andrology, Kansai Medical University, Hirakata, Japan.

Koichiro Akakura (K)

Department of Urology, JCHO Tokyo Shinjuku Medical Center, Tokyo, Japan.

Akira Hata (A)

Department of Public Health, Graduate School of Medicine, Chiba University, Chiba, Japan.

Tomohiko Ichikawa (T)

Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH